27392509|t|Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial)
27392509|a|Biomarker measures of infarct size and myocardial salvage index (MSI) are important surrogate measures of clinical outcomes after a myocardial infarction. However, there is variability in infarct size unaccounted for by conventional adjustment factors. This post hoc analysis of Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events (EMBRACE) ST-Segment Elevation Myocardial Infarction (STEMI) trial evaluates the association between left ventricular (LV) mass and infarct size as assessed by areas under the curve for creatine kinase-MB (CK-MB) and troponin I release over the first 72 hours (CK-MB area under the curve [AUC] and troponin I [TnI] AUC) and the MSI. Patients with first anterior STEMI, occluded left anterior descending artery, and available LV mass measurement in EMBRACE STEMI trial were included (n = 100) (ClinicalTrials.govNCT01572909). MSI, end-diastolic LV mass on day 4 cardiac magnetic resonance, and CK-MB and troponin I concentrations were evaluated by a core laboratory. After saturated multivariate analysis, dominance analysis was performed to estimate the contribution of each independent variable to the predicted variance of each outcome. In multivariate models that included age, gender, body surface area, lesion location, smoking, and ischemia time, LV mass remained independently associated with biomarker measures of infarct size (CK-MB AUC p = 0.02, TnI AUC p = 0.03) and MSI (p = 0.003). Dominance analysis demonstrated that LV mass accounted for 58%, 47%, and 60% of the predicted variances for CK-MB AUC, TnI AUC, and MSI, respectively. In conclusion, LV mass accounts for approximately half of the predicted variance in biomarker measures of infarct size. It should be considered as an adjustment variable in studies evaluating infarct size.
27392509	12	33	Left Ventricular Mass	T033	UMLS:C0455825
27392509	38	50	Infarct Size	T038	UMLS:C0027051
27392509	54	116	Anterior Wall ST-Segment Elevation Acute Myocardial Infarction	T038	UMLS:C3839746
27392509	135	140	STEMI	T038	UMLS:C1536220
27392509	141	155	Clinical Trial	T062	UMLS:C0008976
27392509	157	166	Biomarker	T201	UMLS:C0005516
27392509	179	191	infarct size	T038	UMLS:C0027051
27392509	289	310	myocardial infarction	T038	UMLS:C0027051
27392509	345	357	infarct size	T038	UMLS:C0027051
27392509	415	432	post hoc analysis	T170	UMLS:C0026348
27392509	450	460	Myocardial	T017	UMLS:C0027061
27392509	472	480	Bendavia	T103	UMLS:C3529756
27392509	494	512	Reperfusion Injury	T038	UMLS:C0027055
27392509	530	551	Acute Coronary Events	T038	UMLS:C0948089
27392509	562	604	ST-Segment Elevation Myocardial Infarction	T038	UMLS:C1536220
27392509	606	611	STEMI	T038	UMLS:C1536220
27392509	613	618	trial	T062	UMLS:C0008976
27392509	653	679	left ventricular (LV) mass	T033	UMLS:C0455825
27392509	684	696	infarct size	T038	UMLS:C0027051
27392509	738	756	creatine kinase-MB	T058	UMLS:C0523584
27392509	758	763	CK-MB	T058	UMLS:C0523584
27392509	769	779	troponin I	T103	UMLS:C0077401
27392509	769	787	troponin I release	T058	UMLS:C0920210
27392509	813	818	CK-MB	T058	UMLS:C0523584
27392509	850	860	troponin I	T103	UMLS:C0077401
27392509	862	865	TnI	T103	UMLS:C0077401
27392509	905	919	anterior STEMI	T038	UMLS:C3839746
27392509	930	961	left anterior descending artery	T017	UMLS:C0226032
27392509	977	984	LV mass	T033	UMLS:C0455825
27392509	1008	1013	STEMI	T038	UMLS:C1536220
27392509	1014	1019	trial	T062	UMLS:C0008976
27392509	1082	1095	end-diastolic	T201	UMLS:C0442709
27392509	1096	1103	LV mass	T033	UMLS:C0455825
27392509	1113	1139	cardiac magnetic resonance	T058	UMLS:C0412692
27392509	1145	1150	CK-MB	T058	UMLS:C0523584
27392509	1155	1165	troponin I	T103	UMLS:C0077401
27392509	1201	1216	core laboratory	T092	UMLS:C0022877
27392509	1490	1498	ischemia	T038	UMLS:C0022116
27392509	1505	1512	LV mass	T033	UMLS:C0455825
27392509	1552	1561	biomarker	T201	UMLS:C0005516
27392509	1574	1586	infarct size	T038	UMLS:C0027051
27392509	1588	1593	CK-MB	T058	UMLS:C0523584
27392509	1608	1611	TnI	T103	UMLS:C0077401
27392509	1684	1691	LV mass	T033	UMLS:C0455825
27392509	1755	1760	CK-MB	T058	UMLS:C0523584
27392509	1766	1769	TnI	T103	UMLS:C0077401
27392509	1813	1820	LV mass	T033	UMLS:C0455825
27392509	1882	1891	biomarker	T201	UMLS:C0005516
27392509	1904	1916	infarct size	T038	UMLS:C0027051
27392509	1971	1978	studies	T062	UMLS:C2603343
27392509	1990	2002	infarct size	T038	UMLS:C0027051